Novel water-soluble gelatin-based platinum nanoparticles for targeted cancer therapy with enhanced cytotoxicity
Source abstract
Abstract
The development of effective and targeted cancer therapies remains a significant challenge. Platinum-based drugs are widely used but often suffer from limitations such as systemic toxicity and resistance. This study presents a novel approach to address these limitations by developing water-soluble gelatin-based platinum nanoparticles (PtNPs) for enhanced cancer therapy. The incorporation of gelatin and curcumin into these nanoparticles offers potential advantages in terms of biocompatibility, targeted delivery, and synergistic therapeutic effects. The PtNPs were conveniently synthesized using a nanosuspension technique, offering a potentially scalable and straightforward method for nanoparticle production. The synthesized PtNPs were thoroughly characterized using various techniques. The investigation assessed the cytotoxic properties of the PtNPs in MCF-7 (breast cancer) and HepG2 (liver cancer) cell lines. The average size of PtNPs was found to vary around 120-200 nm. The density of platinum metal was supported by EDS and metal mapping analysis. The IC50 values of PtNPs in MCF-7 and HepG2 cancer cell lines were found to be 6.450 and 7.992 mu L/mL, respectively. The incorporation of gelatin and curcumin into platinum nanoparticles represents a unique and innovative strategy for enhancing nanoparticle biocompatibility, targeting, and therapeutic efficacy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Bhushan B (2017) Introduction to Nanotechnology. In: Bhushan, B. (eds) Springer Handbook of Nanotechnology. Springer Handbooks. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54357-3_110.1007/978-3-662-54357-3_1 ↗
2. Nasrollahzadeh M, Sajadi SM, Sajjadi M, Issaabadi Z, Atarod M (2019) (Eds.) Interface Science and Technology. Elsevier 28:1–27. https://doi.org/10.1016/B978-0-12-813586-0.00001-810.1016/B978-0-12-813586-0.00001-8 ↗
3. Emerich DF, Thanos CG (2003) Nanotechnology and medicine. Expert Opin Biol Ther 3(4):655–663. https://doi.org/10.1517/14712598.3.4.65510.1517/14712598.3.4.655 ↗
4. Rabinow B (2004) Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785–796. https://doi.org/10.1038/nrd149410.1038/nrd1494 ↗
5. Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H (2021) Nanoparticles as drug delivery systems. 64:1020-1037. https://doi.org/10.1016/s1734-1140(12)70901-510.1016/s1734-1140(12)70901-5 ↗
6. Ma Y, Cong Z, Gao P, Wang Y (2023) Nanosuspensions technology as a master key for nature products drug delivery and In vivo fate. Eur J Pharm Sci 185:106425. https://doi.org/10.1016/j.ejps.2023.10642510.1016/j.ejps.2023.106425 ↗
7. Huang S, Wu H, Jiang Z, Huang H (2021) Water-based nanosuspensions: Formulation, tribological property, lubrication mechanism, and applications. J Manuf Process 71:625–644. https://doi.org/10.1016/j.jmapro.2021.10.00210.1016/j.jmapro.2021.10.002 ↗
8. Patel VR, Agrawal YK (2011) Nanosuspension: an approach to enhance solubility of drugs. J Adv Pharma Technol Rese 2(2):81–87. https://doi.org/10.4103/2231-4040.8295010.4103/2231-4040.82950 ↗
9. Saka R, Chella N (2021) Nanotechnology for delivery of natural therapeutic substances: a review. Environ Chem Lett 19:1097–1106. https://doi.org/10.1007/s10311-020-01103-910.1007/s10311-020-01103-9 ↗
10. Guan W, Ma Y, Ding S, Liu Y, Song Z, Liu X, Tang L, Wang Y (2022) The technology for improving stability of nanosuspensions in drug delivery. J Nanopart Res 24:1410.1007/s11051-022-05403-9 ↗
11. Pınar SG, Oktay AN, Karaküçük AE, Çelebi N (2023) Formulation strategies of nanosuspensions for various administration routes. Pharmaceutics 15(5):1520. https://doi.org/10.3390/pharmaceutics1505152010.3390/pharmaceutics15051520 ↗
12. Zhang J, Xie Z, Zhang N, Zhong J (2017) Nanosuspension Drug Delivery System: Preparation, Characterization, Postproduction Processing, Dosage Form, and Application. Elsevier Inc.: Amsterdam, The Netherlands, 413–443. https://doi.org/10.1016/B978-0-323-46143-6.00013-010.1016/B978-0-323-46143-6.00013-0 ↗
13. Sutradhar KB, Khatun S, Luna IP (2013) Increasing possibilities of nanosuspension. J Nanotechnol 2013:346581. https://doi.org/10.1155/2013/34658110.1155/2013/346581 ↗
14. Müller RH, Gohla S, Keck CM (2011) State of the art of nanocrystals—Special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm 78:1–9. https://doi.org/10.1016/j.ejpb.2011.01.00710.1016/j.ejpb.2011.01.007 ↗
15. Jacob S, Nair AB, Shah J (2020) Emerging role of nanosuspensions in drug delivery systems. Biomater Res 24:3. https://doi.org/10.1186/s40824-020-0184-810.1186/s40824-020-0184-8 ↗
16. Joshi K, Chandra A, Jain K, Talegaonkar S (2019) Nanocrystalization: An emerging technology to enhance the bioavailability of poorly soluble drugs. Pharm Nanotechnol 7:259–278. https://doi.org/10.2174/221173850766619040518252410.2174/2211738507666190405182524 ↗
17. Möschwitzer JP (2013) Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm 453:142–156. https://doi.org/10.1016/j.ijpharm.2012.09.03410.1016/j.ijpharm.2012.09.034 ↗
18. Alipal J, MohdPu’ad NAS, Lee TC, Nayan NHM, Sahari N, Basri H, Idris MI, Abdullah HZ (2021) A review of gelatin: Properties, sources, process, applications, and commercialization. Mater Today: Proceedings 42:240–250. https://doi.org/10.1016/j.matpr.2020.12.92210.1016/j.matpr.2020.12.922 ↗
19. Liu D, Nikoo M, Boran G, Zhou P, Regenstein JM (2015) Collagen and gelatin. Annual Rev Food Sci Technol 6:527–557. https://doi.org/10.1146/annurev-food-031414-11180010.1146/annurev-food-031414-111800 ↗
20. Hoque ME, Nuge T, Yeow TK, Nordin N, Prasad RGSV (2015) Gelatin based scaffolds for tissue engineering – a review. Polym Res J 9:15–32
21. Su K, Wang C (2015) Recent advances in the use of gelatin in biomedical research. Biotechnol Lett 37:2139–2145. https://doi.org/10.1007/s10529-015-1907-010.1007/s10529-015-1907-0 ↗
22. Bello AB, Kim D, Kim D, Park H, Lee SH (2020) Engineering and functionalization of gelatin biomaterials: from cell culture to medical applications. Tissue Eng Part B 26:164–180. https://doi.org/10.1089/ten.teb.2019.025610.1089/ten.teb.2019.0256 ↗
23. Echave MC, Hernáez-Moya R, Iturriaga L, Pedraz JL, Lakshminarayanan R, Dolatshahi-Pirouz A, Taebnia N, Orive G (2019) Recent advances in gelatin-based therapeutics. Expert Opin Biol Ther 19:773. https://doi.org/10.1080/14712598.2019.161038310.1080/14712598.2019.1610383 ↗
24. Mansouri K, Rasoulpoor S, Daneshkhah A, Abolfathi S, Salari N, Mohammadi M, Rasolpoor S, Shabani S (2020) Clinical effects of curcumin in enhancing cancer therapy: a systematic review. BMC Cancer 20:791. https://doi.org/10.1186/s12885-020-07256-810.1186/s12885-020-07256-8 ↗
25. Senthil R, Sumathi S, Sivakumar PM, Kavukcu SB, Lakshmi T, Ahmed A (2023) Curcumin nanoparticles impregnated collagen/demineralized bone matrix/olive leaves extract biocomposites as a potential bone implant: Preparation, characterization, and biocompatibility. MRS Communications 13:136–142. https://doi.org/10.1557/s43579-023-00324-710.1557/s43579-023-00324-7 ↗
26. Kavukcu SB, Çakır S, Karaer A, Türkmen H, Rethinam S (2021) Curcumin nanoparticles supported gelatin-collagen scaffold: Preparation, characterization, and in vitro study. Toxicol Rep 8:1475–1479. https://doi.org/10.1016/j.toxrep.2021.07.01810.1016/j.toxrep.2021.07.018 ↗
27. Lee WH, Loo CY, Young PM, Traini D, Mason RS, Rohanizadeh R (2014) Recent advances in curcumin nanoformulation for cancer therapy. Expert Opin Drug Deliv 11(8):1183–1201. https://doi.org/10.1517/17425247.2014.91668610.1517/17425247.2014.916686 ↗
28. Patra JK, Das G, Fraceto LF, Campos EVR, del Pilar R-T, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S, Shin H-S (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16:71. https://doi.org/10.1186/s12951-018-0392-810.1186/s12951-018-0392-8 ↗
29. Materón EM, Miyazaki CM, Carr O, Joshi N, Picciani PH, Dalmaschio CJ, Davis F, Shimizu FM (2021) Magnetic nanoparticles in biomedical applications: A review. Appl Surf Sci Adv 6:100163. https://doi.org/10.1016/j.apsadv.2021.10016310.1016/j.apsadv.2021.100163 ↗
30. Gholami-Shabani M, Sotoodehnejadnematalahi F, Shams-Ghahfarokhi M, Eslamifar A, Razzaghi-Abyaneh M (2022) Platinum nanoparticles as potent anticancer and antimicrobial agent: green synthesis, physical characterization, and in-vitro biological activity. J Cluster Sci 34:501–51610.1007/s10876-022-02225-6 ↗
31. Khan AR, Mamun MSA, Ara MH (2021) Review on platinum nanoparticles: synthesis, characterization, and applications. Microchem J 171:10684010.1016/j.microc.2021.106840 ↗
32. Rethinam S, Vedakumari WS, Basavarajappa S, Hashem MI, Lakshmi T, Senthilvelan T, Kavukcu SB, Venkidasamy B, Vinayagam R (2023) Gelatin/Nanofibrin bioactive scaffold prepared with enhanced biocompatibility for skin tissue regeneration. J Saudi Chem Soc 27(6):101747. https://doi.org/10.1016/j.jscs.2023.10174710.1016/j.jscs.2023.101747 ↗
33. Kavukcu SB, Şahin O, Vatansever HS, Kurt FO, Korkmaz M, Kendirci R, Pelit L, Türkmen H (2020) Synthesis and cytotoxic activities of organometallic Ru (II) diamine complexes. Bioorg Chem 99:103793. https://doi.org/10.1016/j.bioorg.2020.10379310.1016/j.bioorg.2020.103793 ↗
34. Kavukcu SB, Ensarioğlu HK, Karabıyık H, Vatansever HS, Türkmen H (2023) Cell death mechanism of organometallic ruthenium (II) and Iridium (III) Arene complexes on HepG2 and Vero cells. ACS Omega 8(40):37549. https://doi.org/10.1021/acsomega.3c0589810.1021/acsomega.3c05898 ↗
35. Kavukcu SB, Özverel CS, Kıyak N, Vatansever HS, Türkmen H (2024) Ruthenium compounds: are they the next-era anticancer agents? Appl Organomet Chem 38:e7363. https://doi.org/10.1002/aoc.736310.1002/aoc.7363 ↗
36. Long NV, Thi CM, Nogami M, Ohtaki M (2012) Novel issues of morphology, size, and structure of Pt nanoparticles in chemical engineering: surface attachment, aggregation or agglomeration, assembly, and structural changes. New J Chem 36:1320–1334. https://doi.org/10.1039/C2NJ40027H10.1039/C2NJ40027H ↗
37. Beyribey B, Çorbacıoğlu B, Altın Z (2010) Synthesis of platinum particles from H2PtCl6 with hydrazine as reducing agent. Gazi Univ J Sci 22(4):351–357
38. Pedone D, Moglianetti M, De Luca E, Bardi G, Pompa PP (2017) Platinum nanoparticles in nanobiomedicine. Chem Soc Rev 46:4951–4975. https://doi.org/10.1039/C7CS00152E10.1039/C7CS00152E ↗
39. Pawar AA, Sahoo J, Verma A, Lodh A, Lakkakula J (2021) Usage of platinum nanoparticles for anticancer therapy over last decade: a review. Part Part Syst Charact 38:2100115. https://doi.org/10.1002/ppsc.20210011510.1002/ppsc.202100115 ↗
40. Abbasi R, Shineh G, Mobaraki M, Doughty S, Tayebi L (2023) Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review. J Nanopart Res 25:4310.1007/s11051-023-05690-w ↗
41. Rethinam S, Alagumuthu T, Subaramaniyan K, Aruni AW, Kavukcu SB (2021) Preparation of biocompatible polymeric bio-scaffold as wound healing activity: characterization and In vivo analysis. Biocatal Agric Biotechnol 33:101992. https://doi.org/10.1016/j.bcab.2021.10199210.1016/j.bcab.2021.101992 ↗
42. Baskaran B, Muthukumarasamy A, Chidambaram S, Sugumaran A, Ramachandran K, RasuManimuthu T (2017) Cytotoxic potentials of biologically fabricated platinum nanoparticles from Streptomyces sp. on MCF-7 breast cancer cells. IET Nanobiotechnol 11:241–246. https://doi.org/10.1049/iet-nbt.2016.004010.1049/iet-nbt.2016.0040 ↗
43. Sahin B, Aygün A, Gündüz H, Sahin K, Demir E, Akocak S, Sen F (2018) Cytotoxic effects of platinum nanoparticles obtained from pomegranate extract by the green synthesis method on the MCF-7 cell line. Colloids Surf B Biointerfaces 163:119–124. https://doi.org/10.1016/j.colsurfb.2017.12.04210.1016/j.colsurfb.2017.12.042 ↗
44. Alshatwi AA, Athinarayanan J, Subbarayan PV (2015) Green synthesis of platinum nanoparticles that induce cell death and G2/M-phase cell cycle arrest in human cervical cancer cells. J Mater Sci Mater Med 26(1):5330. https://doi.org/10.1007/s10856-014-5330-110.1007/s10856-014-5330-1 ↗
45. Gurunathan S, Kang MH, Jeyaraj M, Kim JH (2021) Platinum nanoparticles enhance exosome release in human lung epithelial adenocarcinoma cancer cells (A549): oxidative stress and the ceramide pathway are key players. Int J Nanomed 16:515–538. https://doi.org/10.2147/IJN.S29113810.2147/IJN.S291138 ↗
46. Shingu T, Chumbalkar VC, Gwak H-S, Fujiwara K, Kondo S, Farrell NP, Bogler O (2010) The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells. Neuro Oncol 12(12):1269–1277. https://doi.org/10.1093/neuonc/noq09510.1093/neuonc/noq095 ↗
47. Ramanathan E, Ponnuchamy K, Muthusamy G, Varathajaran N, Sabapathi D, Selvaraj A (2023) Chitosan-stabilized platinum nanoparticles induce apoptotic cell death in breast cancer cells. Appl Nanosci 13:3867–3873. https://doi.org/10.1007/s13204-022-02598-010.1007/s13204-022-02598-0 ↗
48. Surucu O (2022) Electrochemical removal and simultaneous sensing of mercury with inductively coupled plasma-mass spectrometry from drinking water. Mater Today Chem 23:10063910.1016/j.mtchem.2021.100639 ↗